0 CHECKOUT

Microfluidics Market by Material (Polymer, Glass, Silicon) Application (Pharmaceutical (Genomics, Proteomics, Capillary Electrophoresis) Diagnostic (Clinical, Environmental, Industrial) Drug Delivery (Inhaler, Micropump)) - Global Forecast to 2020

  • ID: 3292463
  • June 2015
  • Region: Global
  • 192 Pages
  • Markets and Markets
The Global Microfluidics Market Is Valued at $3 Billion In 2015 and Is Poised to Grow at a CAGR Of 19% During The Forecast Period (2015 To 2020)

FEATURED COMPANIES

  • Cepheid Inc.
  • Danaher Corporation
  • Fluidigm Corporation
  • Illumina, Inc.
  • Perkinelmer, Inc.
  • Roche Diagnostics Ltd.
  • MORE

Over the past five years, the microfluidics market has witnessed tremendous growth primarily due to rising demand for point-of-care (POC) testing, increasing use of miniaturized microfluidic chips to achieve faster testing and improved portability, and increased prevalence of age-related and lifestyle diseases and disorders.

The global microfluidics market is expected to grow at a significant CAGR of around 19% during the forecast period (2015 to 2020). The market is mainly driven by the rising geriatric population, growing Asian healthcare market, and upsurge in government and corporate funding for R&D. However, lack of adequate healthcare and research infrastructure in emerging markets, dearth of skilled professionals in clinical laboratories, and high prices of integrated instruments and microfluidics chips are hampering the growth of this market to a certain extent.

In this report, the global microfluidics market is segmented on the basis of materials and applications. On the basis of applications, the microfluidics market is divided into pharmaceutical research, in vitro diagnostics, and drug delivery. The pharmaceutical research segment is further divided into READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cepheid Inc.
  • Danaher Corporation
  • Fluidigm Corporation
  • Illumina, Inc.
  • Perkinelmer, Inc.
  • Roche Diagnostics Ltd.
  • MORE

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency and Pricing
1.5 Stakeholders

2 Research Methodology
2.1 Research Approach
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.4.1 Key Data From Secondary Sources
2.4.3 Key Industry Insights
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Growth Potential of the Global Microfluidics Market
4.2 Asia-Pacific: Microfluidics Market, By Product (2014)
4.3 Geographical Snapshot of the Global Microfluidics Market
4.4 North America to Dominate the Global Microfluidics Market During the Forecast Period
4.5 Global Microfluidics Market: Developed vs. Developing Countries

5 Market Overview
Key Findings
5.1 Introduction
5.2 Market Segmentation
5.2.1 Microfluidics Market, By Material
5.2.2 Microfluidics Market, By Application
5.3 Key Market Dynamics
5.3.1 Market Drivers
5.3.1.1 Rising Demand for Point-Of-Care (PoC) Testing
5.3.1.2 Quick Returns on Investment
5.3.1.3 Faster Testing and Improved Portability Through Microfluidic Chip Miniaturization
5.3.2 Market Restraints
5.3.2.1 Incorporation of Microfluidics Technology Into Existing Workflows
5.3.2.2 Complex and Time Consuming Regulatory Approval Process
5.3.3 Market Opportunities
5.3.3.1 Growing Asian Market
5.3.3.2 Expanding Applications of Drug Delivery Technologies
5.3.4 Market Challenges
5.3.4.1 Lack of Market Visibility for Microfluidics Products
5.3.4.2 High Cost of Integrated Instruments and Microfluidic Sensors

6 Industry Insights

7 Global Microfluidics Market, By Material
7.1 Introduction
7.2 Polymer-Based Microfluidics
7.3 Glass-Based Microfluidics
7.4 Silicon-Based Microfluidics
7.5 Other Material-Based Microfluidics

8 Microfluidics Market, By Application
Key Findings
8.1 Introduction
8.2 Pharmaceutical Research
8.2.1 Lab Analytics
8.2.1.1 Cell-Based Assays
8.2.1.2 Proteomic Analysis
8.2.1.3 Genomic Analysis
8.2.1.4 Capillary Electrophoresis
8.2.2 Microdispensing
8.2.3 Microreaction
8.3 in Vitro Diagnostics
8.3.1 Clinical Diagnostics
8.3.2 Point-Of-Care Testing
8.3.3 Environmental Testing
8.3.4 Industrial Testing
8.3.5 Agro Food Testing
8.4 Drug Delivery
8.4.1 Inhalers
8.4.2 Microneedles
8.4.3 Micropumps

9 Global Microfluidics Market, By Region
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest of Asia-Pacific
9.5 Rest of the World (RoW)
9.5.1 Latin America
9.5.2 Middle East and Africa

10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Situation and Trends
10.4 New Product Launches
10.5 Expansion
10.6 Agreements, Partnerships, and Collaborations
10.7 Mergers and Acquisitions

11 Company Profiles
11.1 Introduction
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Business Overview
11.1.2 Product Offerings
11.1.3 Recent Developments
11.1.4 MnM View
11.2 Becton, Dickinson and Company
11.2.1 Business Overview
11.2.2 Product Offerings
11.2.3 Recent Developments
11.2.4 MnM View
11.3 Bio-Rad Laboratories, Inc.
11.3.1 Business Overview
11.3.2 Product Offerings
11.3.3 Recent Developments
11.3.4 MnM View
11.4 Perkinelmer, Inc.
11.4.1 Business Overview
11.4.2 Product Offerings
11.4.3 Recent Developments
11.4.4 MnM View
11.5 Agilent Technologies, Inc.
11.5.1 Business Overview
11.5.2 Product Offerings
11.5.3 Recent Developments
11.5.4 MnM View
11.6 Danaher Corporation
11.6.1 Business Overview
11.6.2 Product Offerings
11.6.3 Recent Developments
11.7 Cepheid Inc.
11.7.1 Business Overview
11.7.2 Product Offerings
11.7.3 Recent Developmets
11.8 Fluidigm Corporation
11.8.1 Business Overview
11.8.2 Product Offerings
11.8.3 Recent Developmets
11.9 Biofluidix GmbH
11.9.1 Business Overview
11.9.2 Product Offerings
11.9.3 Recent Developmets
11.10 Bartels Mikrotechnik GmbH
11.10.1 Business Overview
11.10.2 Product Offerings
11.10.3 Recent Developmets

12 Appendix
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Available Customizations
12.4 Related Reports
12.5 Introducing RT: Real-Time Market Intelligence

List of Tables

Table 1 Global Microfluidics Market Size, By Material, 2013–2020 ($Million)
Table 2 Global Polymer-Based Microfluidics Market Size, By Country, 2013–2020 ($Million)
Table 3 Global Glass-Based Microfluidics Market Size, By Country, 2013–2020 ($Million)
Table 4 Global Silicon-Based Microfluidics Market Size, By Country, 2013–2020 ($Million)
Table 5 Global Other Material-Based Microfluidics Market Size, By Country, 2013–2020 ($Million)
Table 6 Global Microfluidics Market Size, By Application, 2013–2020 ($Million)
Table 7 Global Microfluidics Market Size for Pharmaceutical Research, By Type, 2013–2020 ($Million)
Table 8 Global Microfluidics Market Size for Pharmaceutical Research, By Country/Region, 2013–2020 ($Million)
Table 9 Global Microfluidic Lab Analytics Market Size, By Type, 2013–2020 ($Million)
Table 10 Global Microfluidic Lab Analytics Market Size, By Country/Region, 2013–2020 ($Million)
Table 11 Global Microfluidics Market Size for Cell-Based Assays, By Country, 2013–2020 ($Million)
Table 12 Global Microfluidics Market Size for Proteomic Analysis, By Country, 2013–2020 ($Million)
Table 13 Global Microfluidics Market Size for Genomic Analysis, By Country, 2013–2020 ($Million)
Table 14 Global Microfluidics Market Size for Capillary Electrophoresis, By Country, 2013–2020 ($Million)
Table 15 Global Microfluidics Market Size for Micro dispensing, By Country, 2013–2020 ($Million)
Table 16 Global Microfluidics Market Size for Micro reaction, By Country, 2013–2020 ($Million)
Table 17 Global Microfluidics Market Size for in Vitro Diagnostics, By Type, 2013–2020 ($Million)
Table 18 Global Microfluidics Market Size for in Vitro Diagnostics, By Country, 2013–2020 ($Million)
Table 19 Global Microfluidics Market Size for Clinical Diagnostics, By Country, 2013–2020 ($Million)
Table 20 Global Microfluidics Market Size for Point-Of-Care Testing, By Country, 2013–2020 ($Million)
Table 21 Global Microfluidics Market Size for Environmental Testing, By Country, 2013–2020 ($Million)
Table 22 Global Microfluidics Market Size for Industrial Testing, By Country, 2013–2020 ($Million)
Table 23 Global Microfluidics Market Size for Agro Food Testing, By Country, 2013–2020 ($Million)
Table 24 Global Microfluidics Market Size for Drug Delivery, By Type, 2013–2020 ($Million)
Table 25 Global Microfluidics Market Size for Drug Delivery, By Country, 2013–2020 ($Million)
Table 26 Global Microfluidics Inhalers Market Size, By Country, 2013–2020 ($Million)
Table 27 Global Microneedles Market Size, By Country, 2013–2020 ($Million)
Table 28 Global Micropumps Market Size, By Country, 2013–2020 ($Million)
Table 29 North America: Microfluidics Market Size, By Country, 2013–2020 ($Million)
Table 30 North America: Microfluidics Market Size, By Application, 2013–2020 ($Million)
Table 31 North America: Microfluidics Market Size for Pharmaceutical Research Application, By Type, 2013–2020 ($Million)
Table 32 North America: Microfluidics Market Size for Lab Analytics Application, By Type, 2013–2020 ($Million)
Table 33 North America: Microfluidics Market Size for In-Vitro Diagnostics Application, By Type, 2013–2020 ($Million)
Table 34 North America: Microfluidics Market Size for Drug Delivery Application, By Type, 2013–2020 ($Million)
Table 35 U.S.: Microfluidics Market Size, By Material, 2013–2020 ($Million)
Table 36 U.S.: Microfluidics Market Size, By Application, 2013–2020 ($Million)
Table 37 U.S.: Microfluidics Market Size for Pharmaceutical Research Application, By Type, 2013–2020 ($Million)
Table 38 U.S.: Microfluidics Market Size for Lab Analytics Application, By Type, 2013–2020 ($Million)
Table 39 U.S.: Microfluidics Market Size for In-Vitro Diagnostics Application, By Type, 2013–2020 ($Million)
Table 40 U.S.: Microfluidics Market Size for Drug Delivery Application, By Type, 2013–2020 ($Million)
Table 41 Canada: Microfluidics Market Size, By Application, 2013–2020 ($Million)
Table 42 Canada: Microfluidics Market Size for Pharmaceutical Research Application, By Type, 2013–2020 ($Million)
Table 43 Canada: Microfluidics Market Size for Lab Analytics Application, By Type, 2013–2020 ($Million)
Table 44 Canada: Microfluidics Market Size for In-Vitro Diagnostics Application, By Type, 2013–2020 ($Million)
Table 45 Canada: Microfluidics Market Size for Drug Delivery Application, By Type, 2013–2020 ($Million)
Table 46 Europe: Microfluidics Market Size, By Country/Region, 2013–2020 ($Million)
Table 47 Europe: Microfluidics Market Size, By Application, 2013–2020 ($Million)
Table 48 Europe: Microfluidics Market Size for Pharmaceutical Research Application, By Type, 2013–2020 ($Million)
Table 49 Europe: Microfluidics Market Size for Lab Analytics Application, By Type, 2013–2020 ($Million)
Table 50 Europe: Microfluidics Market Size for In-Vitro Diagnostics Application, By Type, 2013–2020 ($Million)
Table 51 Europe: Microfluidics Market Size for Drug Delivery Application, By Type, 2013–2020 ($Million)
Table 52 Germany: Microfluidics Market Size, By Application, 2013–2020 ($Million)
Table 53 Germany: Microfluidics Market Size for Pharmaceutical Research Application, By Type, 2013–2020 ($Million)
Table 54 Germany: Microfluidics Market Size for Lab Analytics Application, By Type, 2013–2020 ($Million)
Table 55 Germany: Microfluidics Market Size for In-Vitro Diagnostics Application, By Type, 2013–2020 ($Million)
Table 56 Germany: Microfluidics Market Size for Drug Delivery Application, By Type, 2013–2020 ($Million)
Table 57 France: Microfluidics Market Size, By Application, 2013–2020 ($Million)
Table 58 France: Market Size for Pharmaceutical Research Application, By Type, 2013–2020 ($Million)
Table 59 France: Microfluidics Market Size for Lab Analytics Application, By Type, 2013–2020 ($Million)
Table 60 France: Microfluidics Market Size for In-Vitro Diagnostics Application, By Type, 2013–2020 ($Million)
Table 61 France: Microfluidics Market Size for Drug Delivery Application, By Type, 2013–2020 ($Million)
Table 62 U.K.: Microfluidics Market Size, By Application, 2013–2020 ($Million)
Table 63 U.K.: Microfluidics Market Size for Pharmaceutical Research Application, By Type, 2013–2020 ($Million)
Table 64 U.K.: Microfluidics Market Size for Lab Analytics Application, By Type, 2013–2020 ($Million)
Table 65 U.K.: Microfluidics Market Size for In-Vitro Diagnostics Application, By Type, 2013–2020 ($Million)
Table 66 U.K.: Microfluidics Market Size for Drug Delivery Application, By Type, 2013–2020 ($Million)
Table 67 Italy: Microfluidics Market Size, By Application, 2013–2020 ($Million)
Table 68 Italy: Microfluidics Market Size for Pharmaceutical Research Application, By Type, 2013–2020 ($Million)
Table 69 Italy: Microfluidics Market Size for Lab Analytics Application, By Type, 2013–2020 ($Million)
Table 70 Italy: Microfluidics Market Size for In-Vitro Diagnostics Application, By Type, 2013–2020 ($Million)
Table 71 Italy: Microfluidics Market Size for Drug Delivery Application, By Type, 2013–2020 ($Million)
Table 72 Spain: Microfluidics Market Size, By Application, 2013–2020 ($Million)
Table 73 Spain: Microfluidics Market Size for Pharmaceutical Research Application, By Type, 2013–2020 ($Million)
Table 74 Spain: Microfluidics Market Size for Lab Analytics Application, By Type, 2013–2020 ($Million)
Table 75 Spain: Microfluidics Market Size for In-Vitro Diagnostics Application, By Type, 2013–2020 ($Million)
Table 76 Spain: Microfluidics Market Size for Drug Delivery Application, By Type, 2013–2020 ($Million)
Table 77 RoE: Microfluidics Market Size, By Application, 2013–2020 ($Million)
Table 78 RoE: Microfluidics Market Size for Pharmaceutical Research Application, By Type, 2013–2020 ($Million)
Table 79 RoE: Microfluidics Market Size for Lab Analytics Application, By Type, 2013–2020 ($Million)
Table 80 RoE: Microfluidics Market Size for In-Vitro Diagnostics Application, By Type, 2013–2020 ($Million)
Table 81 RoE: Microfluidics Market Size for Drug Delivery Application, By Type, 2013–2020 ($Million)
Table 82 APAC: Microfluidics Market Size, By Country/Region, 2013–2020 ($Million)
Table 83 APAC: Microfluidics Market Size, By Application, 2013–2020 ($Million)
Table 84 APAC: Microfluidics Market Size for Pharmaceutical Research Application, By Type, 2013–2020 ($Million)
Table 85 APAC: Microfluidics Market Size for Lab Analytics Application, By Type, 2013–2020 ($Million)
Table 86 APAC: Market Size for In-Vitro Diagnostics Application, By Type, 2013–2020 ($Million)
Table 87 APAC: Microfluidics Market Size for Drug Delivery Application, By Type, 2013–2020 ($Million)
Table 88 Japan: Microfluidics Market Size, By Application, 2013–2020 ($Million)
Table 89 Japan: Market Size for Pharmaceutical Research Application, By Type, 2013–2020 ($Million)
Table 90 Japan: Microfluidics Market Size for Lab Analytics Application, By Type, 2013–2020 ($Million)
Table 91 Japan: Microfluidics Market Size for In-Vitro Diagnostics Application, By Type, 2013–2020 ($Million)
Table 92 Japan: Microfluidics Market Size for Drug Delivery Application, By Type, 2013–2020 ($Million)
Table 93 China: Microfluidics Market Size, By Application, 2013–2020 ($Million)
Table 94 China: Microfluidics Market Size for Pharmaceutical Research Application, By Type, 2013–2020 ($Million)
Table 95 China: Microfluidics Market Size for Lab Analytics Application, By Type, 2013–2020 ($Million)
Table 96 China: Microfluidics Market Size for In-Vitro Diagnostics Application, By Type, 2013–2020 ($Million)
Table 97 China: Microfluidics Market Size for Drug Delivery Application, By Type, 2013–2020 ($Million)
Table 98 India: Microfluidics Market Size, By Application, 2013–2020 ($Million)
Table 99 India: Market Size for Pharmaceutical Research Application, By Type, 2013–2020 ($Million)
Table 100 India: Microfluidics Market Size for Lab Analytics Application, By Type, 2013–2020 ($Million)
Table 101 India: Market Size for In-Vitro Diagnostics Application, By Type, 2013–2020 ($Million)
Table 102 India: Microfluidics Market Size for Drug Delivery Application, By Type, 2013–2020 ($Million)
Table 103 RoAPAC: Microfluidics Market Size, By Application, 2013–2020 ($Million)
Table 104 RoAPAC: Microfluidics Market Size for Pharmaceutical Research Application, By Type, 2013–2020 ($Million)
Table 105 RoAPAC: Microfluidics Market Size for Lab Analytics Application, By Type, 2013–2020 ($Million)
Table 106 RoAPAC: Microfluidics Market Size for In-Vitro Diagnostics Application, By Type, 2013–2020 ($Million)
Table 107 RoAPAC: Microfluidics Market Size for Drug Delivery Application, By Type, 2013–2020 ($Million)
Table 108 RoW: Microfluidics Market Size, By Region, 2013–2020 ($Million)
Table 109 RoW: Market Size, By Application, 2013–2020 ($Million)
Table 110 RoW: Microfluidics Market Size for Pharmaceutical Research Application, By Type, 2013–2020 ($Million)
Table 111 RoW: Microfluidics Market Size for Lab Analytics Application, By Type, 2013–2020 ($Million)
Table 112 RoW: Microfluidics Market Size for In-Vitro Diagnostics Application, By Type, 2013–2020 ($Million)
Table 113 RoW: Microfluidics Market Size for Drug Delivery Application, By Type, 2013–2020 ($Million)
Table 114 Latin America: Microfluidics Market Size, By Application, 2013–2020 ($Million)
Table 115 Latin America: Market Size for Pharmaceutical Research Application, By Type, 2013–2020 ($Million)
Table 116 Latin America: Microfluidics Market Size for Lab Analytics Application, By Type, 2013–2020 ($Million)
Table 117 Latin America: Microfluidics Market Size for In-Vitro Diagnostics Application, By Type, 2013–2020 ($Million)
Table 118 Latin America: Microfluidics Market Size for Drug Delivery Application, By Type, 2013–2020 ($Million)
Table 119 Middle East and Africa: Microfluidics Market Size, By Application, 2013–2020 ($Million)
Table 120 Middle East and Africa: Microfluidics Market Size for Pharmaceutical Research Application, By Type, 2013–2020 ($Million)
Table 121 Middle East and Africa: Microfluidics Market Size for Lab Analytics Application, By Type, 2013–2020 ($Million)
Table 122 Middle East and Africa: Market Size for In-Vitro Diagnostics Application, By Type, 2013–2020 ($Million)
Table 123 Middle East and Africa: Microfluidics Market Size for Drug Delivery Application, By Type, 2013–2020 ($Million)

List of Figures

Figure 1 Global Microfluidics Market, By Material
Figure 2 Global Microfluidics Market, By Application
Figure 3 Research Design
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Bottom-Up Approach
Figure 6 Top-Down Approach
Figure 7 Data Triangulation Methodology
Figure 8 Polymer-Based Microfluidics to Register Maximum Growth During the Forecast Period
Figure 9 In-Vitro Diagnostics Application is Expected to Dominate the Global Microfluidics Instruments Market By 2020
Figure 10 Geographic Analysis: Global Microfluidics Market (2014)
Figure 11 Rising Incidence of Cancer and Aids to Drive Market Growth
Figure 12 Spectrophotometers Accounted for the Largest Share of the Asia-Pacific Microfluidics Instrumentation Market
Figure 13 The U.S. Held the Largest Share of the Microfluidics Market in 2014
Figure 14 Global Microfluidics Market, By Region (2013–2020)
Figure 15 China to Register Highest Growth Rate During the Forecast Period
Figure 16 Microfluidics Market Segmentation, By Material
Figure 17 Microfluidics Market Segmentation, By Application
Figure 18 Microfluidics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 New Product Launches Was the Key Growth Strategy Adopted By Market Players in the Last Three Years (2012-2014)
Figure 20 Global Microfluidics Market Share Analysis, By Key Player, 2014
Figure 21 Battle for Market Share: New Product Launches Was the Key Strategy
Figure 22 Geography Revenue Mix of Top Market Players
Figure 23 Thermo Fisher Scientific, Inc.: Company Snapshot
Figure 24 Becton, Dickinson and Company: Company Snapshot
Figure 25 Bio-Rad Laboratories, Inc.: Company Snapshot
Figure 26 Perkinelmer, Inc.: Company Snapshot
Figure 27 Agilent Technologies, Inc.: Company Snapshot
Figure 28 Danaher Corporation: Company Snapshot
Figure 29 Cepheid Inc.: Company Snapshot
Figure 30 Fluidigm Corporation: Company Snapshot
Figure 31 Biofluidix GmbH: Company Snapshot
Figure 32 Bartels Mikrotechnik GmbH: Company Snapshot

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cepheid Inc.
  • Danaher Corporation
  • Fluidigm Corporation
  • Illumina, Inc.
  • Perkinelmer, Inc.
  • Roche Diagnostics Ltd.
  • MORE

The global microfluidics market is valued at $3 Billion in 2015 and is poised to grow at a CAGR of 19% during the forecast period (2015 to 2020). This market is mainly driven by the rising demand for point-of-care (POC) testing, increasing demand for microfluidic chip miniaturization as it offers lower testing time and improved portability, growing Asian market, rising incidences of lifestyle diseases, increasing R&D expenditure and healthcare spending, and growing stem cell and cancer research. However, complex and time-consuming regulatory approval process, high cost of integrated instruments and microfluidic sensors, and lack of market visibility for microfluidics products are inhibiting the growth of this market to a certain extent.

The global microfluidics market is segmented on the basis of materials and applications. On the basis of materials, the market is categorized into polymer-based microfluidics, glass-based microfluidics, silicon-based microfluidics, and other material-based microfluidics. On the basis of applications, the microfluidics market is divided into pharmaceutical research, in vitro diagnostics, and drug delivery. The pharmaceutical research segment is further segmented into lab analytics (cell-based assays, proteomic analysis, genomic analysis, and capillary electrophoresis), dispensing, and microreaction. The in vitro diagnostics application segment is further divided into clinical diagnostics, point-of-care testing, environmental testing, industrial testing, and agro food testing. The drug delivery application segment is divided into inhalers, microneedles, and micropumps.

On the basis of regions, this market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW), which is further analyzed at country levels. The research report discusses the key market drivers, restraints, challenges, and opportunities in the global market and its submarkets.

In 2014, the in vitro diagnostics application segment accounted for the largest share of the global microfluidics market, primarily owing to the rising incidences of chronic diseases, growing demand for point-of-care testing, and rising aging population.

North America accounted for the largest share in 2014, followed by Europe, Asia-Pacific, and RoW. The Asia-Pacific region represents the fastest-growing market for microfluidics products, primarily due to the increasing R&D and healthcare expenditure and growth in the overall healthcare industry. In addition, increasing investments in the healthcare industry by key market players, rising demand for cutting-edge technologies, and expansion of private sector hospitals to rural areas in countries such as China, Taiwan, and India are driving the growth of this region.

The market is highly fragmented with the presence of several large and small market players. Major players in the global microfluidics market are Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Agilent Laboratories, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), and Becton, Dickinson and Company (U.S.).

Note: Product cover images may vary from those shown

- Agilent Technologies, Inc.
- Becton, Dickinson And Company
- Bio-Rad Laboratories, Inc.
- Cepheid Inc.
- Danaher Corporation
- Fluidigm Corporation
- Illumina, Inc.
- Perkinelmer, Inc.
- Roche Diagnostics Ltd.
- Thermo Fisher Scientific, Inc.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user licence, allowing up to five users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Bayer AG
  • LEO Laboratories Ltd.
  • Grünenthal GmbH
  • Medtronic, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Pall Corporation